MedPath
NMPA Approval

Ebastine Oral Solution

国药准字H20249219

October 29, 2024

Drug Information

依巴斯汀口服溶液

口服溶液剂

120ml:120mg

化学药品

October 29, 2024

Company Information

Applicant Company

长沙高新开发区麓谷街道竹韵路30号试验检测楼101四楼

Manufacturing Company

南京市江北新区科创大道18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

依巴斯汀口服溶液 - NMPA 批准文号 | MedPath